The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial.
about
Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis.Progressing haemorrhagic stroke: categories, causes, mechanisms and managements.The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial.Risks and benefits of CT angiography in spontaneous intracerebral hemorrhageSecondary Hematoma Expansion and Perihemorrhagic Edema after Intracerebral Hemorrhage: From Bench Work to Practical Aspects.Effect of CTA Tube Current on Spot Sign Detection and Accuracy for Prediction of Intracerebral Hemorrhage Expansion.Ultraearly hematoma growth in active intracerebral hemorrhage.Adaptive sample size modification in clinical trials: start small then ask for more?Association Between Serum Calcium Level and Extent of Bleeding in Patients With Intracerebral Hemorrhage.CM352 Reduces Brain Damage and Improves Functional Recovery in a Rat Model of Intracerebral Hemorrhage.Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial.The CT Swirl Sign Is Associated with Hematoma Expansion in Intracerebral Hemorrhage.Tranexamic acid for acute intracerebral hemorrhage growth predicted by spot sign trial: Rationale and design.Software output from semi-automated planimetry can underestimate intracerebral haemorrhage and peri-haematomal oedema volumes by up to 41.Audit of CT reporting standards in cases of intracerebral haemorrhage at a comprehensive stroke centre in Australia.Prevention of haematoma progression by tranexamic acid in intracerebral haemorrhage patients with and without spot sign on admission scan: a statistical analysis plan of a pre-specified sub-study of the TICH-2 trial.Treatment of intracerebral haemorrhage with tranexamic acid – A review of current evidence and ongoing trials
P2860
Q33676496-BBDDC77C-1048-4DAF-94D7-8BE768FF8B9FQ34459723-0B6B6576-D044-4F7C-9CB2-6068496C3066Q37689602-F606D89F-FB4A-4248-814A-4D6D3CFAD563Q37705693-44833C61-DBFA-4CBB-8EA7-C49C773968DBQ37740548-70F8BDE6-619D-4E4D-8BB5-11D4787DAAC1Q38865071-8FF64557-8F20-4EEE-903E-1DFA08F85F47Q39656102-14F6D6E7-053A-403B-BDAF-31E7FF583F16Q40739745-BEF93E6F-8C34-4D63-B670-67E8CDF3447AQ43097548-D4F5A85D-9FE8-47BD-A9FD-873AFEB521FBQ47165301-58388E0E-DB44-475C-A91B-E667FC65E7E9Q47443820-7815369C-0250-4BBA-8258-E34C01DB119EQ47566453-334B43CD-2935-4805-A64A-799328B83529Q50747159-65B06349-4F7B-4325-A980-C03D0247E09BQ52981906-AF5F75D2-6698-482A-9A47-8C5BA3E769FBQ52981914-650A334B-417E-46DC-939D-A73BE1ED44C8Q55286673-B8C4CF52-93D0-4FB9-A08A-31DB12298EB6Q58438976-BF04F7C0-C658-4A9B-A0DE-02BB2F47BD9A
P2860
The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The spot sign and tranexamic a ...... uble-blind, multicenter trial.
@en
The spot sign and tranexamic a ...... uble-blind, multicenter trial.
@nl
type
label
The spot sign and tranexamic a ...... uble-blind, multicenter trial.
@en
The spot sign and tranexamic a ...... uble-blind, multicenter trial.
@nl
prefLabel
The spot sign and tranexamic a ...... uble-blind, multicenter trial.
@en
The spot sign and tranexamic a ...... uble-blind, multicenter trial.
@nl
P2093
P2860
P50
P356
P1476
The spot sign and tranexamic a ...... ouble-blind, multicenter trial
@en
P2093
Andrew Lee
Christen Barras
Christopher Bladin
Jayantha Rupasinghe
Jonathan Sturm
Jorge Zavala
Leonid Churilov
Mark W Parsons
Peter Mitchell
Richard I Aviv
P2860
P304
P356
10.1111/IJS.12132
P50
P577
2013-08-26T00:00:00Z